secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2021-11-17T23:59:59+00:00
Accession:  0001764013-21-000123
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant to present corporate overview at Stifel Virtual Healthcare Conference Nov 17
--------------------------------------------------------------------------------

- CEO Pete Salzmann to present at Stifel 2021 Virtual Healthcare Conference on Nov 17, 2021 at 2:00pm ET.
- Webcast available on Immunovant's investor relations website.
- No material financial or operational updates disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401321000123/0001764013-21-000123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401321000123/imvt-20211112.htm
  HTML page:      https://secwatch.observer/filing/0001764013-21-000123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer